Brief: Cytotools to expand clinical development program for DermaPro in U.S.

bioXXmed AG

17/11/2014 07:56

Nov 17 (Reuters) - Cytotools AG  T5OG.DE : 
    * Says expansion of the clinical development program for 
DermaPro in U.S. pharmaceutical market 
    * Says unit Dermatools Biotech GmbH plans to file 
Investigational New Drug application to FDA for DermaPro 
    * Says clinical phase III study in preparation for approval 
of DermaPro in the United States for the treatment of Varicose 
Ulcers (Venous Leg Ulcer = VLU) 
    * Says start of phase III study is planned for the first 
half of 2015 
 
Source text for Eikon:  ID:nEQ8gGKHka  
Further company coverage:  T5OG.DE  
 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;)) 
 
Keywords: CYTOTOOLS/BRIEF